Ascites as a predictor of ovarian malignancy

Gynecologic Oncology

Volumn 87, Issue 1, 2002, Pages 77-83

  Shen Gunther, Jane ^a   Mannel, Robert S ^b  

^a Gynecologic Surgery and Oncology   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Ascites; Ovarian cancer; Pelvic mass; Vascular permeability factor

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; CANCER INVASION; CANCER STAGING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PHYSICAL EXAMINATION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS;

EID: 0036919935     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6800     Document Type: Article

References (25)

1. Manjunath AP, Pratapkumar MD, Sujatha K, Vani R. Comparison of three risk of malignancy indices in evaluation of pelvic masses. Gynecol Oncol 2001;81:225-9.
2. Mol BW, Boll D, De Kanter M, Heintz AP, Sijmons EA, Oei SG, et al. Distinguishing the benign and malignant adnexal mass: An external validation of prognostic models. Gynecol Oncol 2001;80:162-7.
3. Sato S, Yokoyama Y, Sakamoto T, Futagami M, Saito Y. Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonograpy. Cancer 2000;89:582-8.
4. Gynecology. In: Speert H. Obstetrics and Gynecology: A History and Iconography, 2nd Ed. San Francisco: Norman Publishing, 1994:455.
5. Koninckx PR, Renaer M, Brosens IA. Origin of peritoneal fluid in women: an ovarian exudation product. Br J Obstet Gynaecol 1980;87:177-83.
6. Baker AR, Weber JS. Treatment of malignant ascites. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: JB Lippincott; 1993:2255-61.
7. Fastaia J, Dumont AE. Pathogenesis of ascites in mice with peritoneal carcinomatosis. J Natl Cancer Inst 1976;56:547-550.
8. Ackerman NB. Differences in vascular permeability between normal and tumor vessels produced by vasoactive agents. Surg Forum 1973;24:105-7.
9. Coates G, Bush RS, Aspin N. A study of ascites using lymphoscintigraphy with Tc-sulfur colloid. Radiology 1973;107:577-583.
10. Garrison RN, Kaelin LD, Galloway RH, Heuser LS. Malignant ascites: Clinical and experimental observations. Ann Surg 1986;203:644-649.
11. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-5.
12. Nagy JA, Herzberg KT, Masse EM, Zientara, GP, Dvorak HF. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice. Cancer Res 1989;49:5448-58.
13. Nagy JA, Herzberg KT, Dvorak JM, Dvorak HF. Pathogenesis of malignant ascites formation: Initiating events that lead to fluid accumulation. Cancer Res 1993;53:2631-43.
14. Boss EA, Massuger LF, Thomas CM, Geurts-Moespots A, Boonstra H, Sweep CG. Vascular endothelial growth factor in ovarian cyst fluid. Cancer 2001;91:371-7.
15. Shen GH, Ghazizadeh M, Kawanami O, Shimizu H, Jin E, Araki T, et al. Prognostic significance of vascular endothelial growth factor expression in human ovarian cancinoma. Br J Cancer 2000;83:196-203.
16. Abramov Y, Anteby SO, Faouliotis SJ, Barak V. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and inter-leukin 6 in Meigs syndrome. Am J Obstet Gynecol 2001;184:354-5.
17. Ishiko O, Yoshida H, Sumi T, Hirai K, Ogita S. Vascular endothelial growth factor levels in pleural and peritoneal fluid in Meigs' syndrome. Eur J. Obstet Gynecol Reprod Biol 2001;98:129-30.
18. McLaren J. Vascular endothelial growth factor and endometriotic angio-genesis. Hum Reprod Update 2000;6:45-55.
19. Takemore M, Nishimura R, Hasegawa K. Ovarian thecoma with ascites and high serum levels of CA125. Arch Gynecol Obstet 2000:264:42-4.
20. Buttin BM, Cohn DE, Herzog TJ. Meigs' syndrome with an elevated CA 125 from Brenner tumors. Obstet Gynecol 2001:98:980-2.
21. Bilgin T, Karabay A, Dolar E, Develioglu OH. Peritoneal tuberculosis with pelvic abdominal mass, ascites, and elevated CA 125 mimicking advanced ovarian carcinoma: A series of 10 cases. Int J. Gynecol Cancer 2001;11:290-4.
22. Menon U, Jacobs IJ. Tumor markers. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and Practice of Gynecologic Oncology, 3rd Ed. Philadelphia: Lippincott Williams & Wilkins, 2000:165-167.
23. Maathuis JB, Van Look PFA, Michie EA. Changes in volume, total protein and ovarian steroid concentrations of peritoneal fluid throughout the human menstrual cycle. J Endocrinol 1978;76:123-133.
24. Steinkampf JP, Blackwell RE, Younger JB. Visualization of free peritoneal fluid with transvaginal sonography: a preliminary study. J Reprod Med 1991;36:729-30.
25. Nichols JE, Steinkampf MP. Detection of free peritoneal fluid by trans-vaginal sonography. J Clin Ultrasound 1993;21:171-4.